Emergent BioSolutions Inc (EBS)
9.48
+0.08
(+0.85%)
USD |
NYSE |
Nov 22, 16:00
9.41
-0.07
(-0.74%)
After-Hours: 18:54
Emergent BioSolutions Total Assets (Quarterly): 1.478B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.478B |
| June 30, 2024 | 1.514B |
| March 31, 2024 | 1.804B |
| December 31, 2023 | 1.823B |
| September 30, 2023 | 1.893B |
| June 30, 2023 | 2.179B |
| March 31, 2023 | 2.950B |
| December 31, 2022 | 3.166B |
| September 30, 2022 | 2.908B |
| June 30, 2022 | 2.735B |
| March 31, 2022 | 2.780B |
| December 31, 2021 | 2.958B |
| September 30, 2021 | 2.868B |
| June 30, 2021 | 2.915B |
| March 31, 2021 | 2.900B |
| December 31, 2020 | 2.883B |
| September 30, 2020 | 2.616B |
| June 30, 2020 | 2.466B |
| March 31, 2020 | 2.279B |
| December 31, 2019 | 2.327B |
| September 30, 2019 | 2.334B |
| June 30, 2019 | 2.321B |
| March 31, 2019 | 2.154B |
| December 31, 2018 | 2.229B |
| September 30, 2018 | 1.174B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.139B |
| March 31, 2018 | 1.068B |
| December 31, 2017 | 1.070B |
| September 30, 2017 | 1.024B |
| June 30, 2017 | 970.48M |
| March 31, 2017 | 951.64M |
| December 31, 2016 | 970.11M |
| September 30, 2016 | 932.03M |
| June 30, 2016 | 1.056B |
| March 31, 2016 | 1.036B |
| December 31, 2015 | 1.037B |
| September 30, 2015 | 976.55M |
| June 30, 2015 | 943.32M |
| March 31, 2015 | 917.84M |
| December 31, 2014 | 938.69M |
| September 30, 2014 | 869.29M |
| June 30, 2014 | 837.25M |
| March 31, 2014 | 823.25M |
| December 31, 2013 | 626.63M |
| September 30, 2013 | 595.46M |
| June 30, 2013 | 555.61M |
| March 31, 2013 | 538.38M |
| December 31, 2012 | 564.23M |
| September 30, 2012 | 540.02M |
| June 30, 2012 | 527.14M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.478B
Minimum
Sep 2024
3.166B
Maximum
Dec 2022
2.472B
Average
2.676B
Median
Total Assets (Quarterly) Benchmarks
| Geovax Labs Inc | 11.11M |
| Tonix Pharmaceuticals Holding Corp | 94.99M |
| Abbott Laboratories | 74.36B |
| Insulet Corp | 3.025B |
| SIGA Technologies Inc | 195.35M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 969.40M |
| Shareholders Equity (Quarterly) | 508.40M |
| Debt to Equity Ratio | 1.303 |
| Current Ratio | 2.877 |
| Net Debt Paydown Yield | 10.66% |